Gene inhibition using antisense oligodeoxynucleotides
- 1 November 1994
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 372 (6504) , 333-335
- https://doi.org/10.1038/372333a0
Abstract
Antisense oligodeoxynucleotides (ODNs) have great promise as agents for the specific manipulation of gene expression. Until recently, nonspecific effects of ODNs often confounded the interpretation of antisense studies. Improvements in ODN chemistry and cellular delivery techniques now allow for more potent and specific gene inhibition. This review critically evaluates recent progress in the development of antisense ODNs.Keywords
This publication has 46 references indexed in Scilit:
- Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.Journal of Clinical Investigation, 1994
- Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptorNeuron, 1994
- Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.Journal of Clinical Investigation, 1994
- Suppression of Neointimal Smooth Muscle Cell Accumulation in Vivo by Antisense cdc2 and cdk2 Oligonucleotides in Rat Carotid ArteryBiochemical and Biophysical Research Communications, 1994
- BCR-ABL antisense purging in chronic myeloid leukaemiaThe Lancet, 1993
- Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cellsBiochemistry, 1993
- Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brainEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivoNature, 1992
- Selection of single-stranded DNA molecules that bind and inhibit human thrombinNature, 1992
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990